Work

Real‐Time Continuous Glucose Monitoring Use and Kidney Function Among People With Diabetes and CKD or At‐Risk for CKD

Year: 2026

Type: article

Abstract: INTRODUCTION: Continuous glucose monitoring (CGM) use may benefit people with diabetes and chronic kidney disease (CKD). In this propensity-matched, retrospective analysis using Truveta-provided de-identified EMR data, changes in kidney function and glycemia were compared between cohorts starting real-time CGM (RT-CGM) use and CGM non-users (No CGM). METHODS: were included. Changes in eGFR, albumin-to-creatinine ratio (ACR), and HbA1c between baseline and 3-year follow-up were assessed. RESULTS: RT-CGM initiation (N = 518 per cohort) was associated with a significantly slower decline in eGFR compared to No CGM. There was no significant difference in change in ACR between the groups (N = 138 per cohort). RT-CGM use (N = 461 per cohort) was associated with a significantly greater decrease in HbA1c compared to No CGM. CONCLUSIONS: These findings support RT-CGM initiation among people with diabetes and CKD or at risk for CKD.

Source: Endocrinology Diabetes & Metabolism

DOI: 10.1002/edm2.70344

Authors: Katia L. Hannah, Christina Chen, Jessica R. Castle, Gregory J. Norman, Rodolfo J. Galindo

Institutions: Dexcom (United States), University of Miami

Language: English

Topic: Diabetes Management and Research

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,280